1-800-567-8911 or
604-682-5050
(Telephone interpreting in over 150 languages available)
Doravirine + Lamivudine + Tenofovir
Trade Name:
Delstrigo
Manufacturer/Distributor:
Merck Canada Inc.
www.merck.ca
Classification:
Antiviral agent
Status:
active
Notice of Compliance (yyyy/mm/dd):
2018/11/09
Date Marketed in Canada (yyyy/mm/dd):
2018/12/15
Presentation:
Tablet: doravirine 100 mg, lamivudine 300 mg, tenofovir 300 mg. DIN: 02482592
Comments:
Three ingredient preparation for treatment of HIV-1 in adults without past or present evidence of viral resistance to doravirine, lamivudine, or tenofovir.
Back to:
Drug Product Listings 
